FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kyoko Nagasue

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Bone Resorption

Co-author Network

Publications

TOP 3
Mitsuru Ichii; Eiji Ishimura; Senji Okuno; Hidenori Chou; Yoko Kato; Naoki Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Eiji Ishimura; Senji Okuno; K Kono; Y Fujino-Kato; Y Maeno; S Kagitani; N Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kyoko Nagasue (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Mitsuru Ichii; Eiji Ishimura; Senji Okuno; Hidenori Chou; Yoko Kato; Naoki Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Nephron. Clinical practice 2010;115(3):c195-202.
2009: Eiji Ishimura; Senji Okuno; K Kono; Y Fujino-Kato; Y Maeno; S Kagitani; N Tsuboniwa; Kyoko Nagasue; Kiyoshi Maekawa; Tomoyuki Yamakawa; Masaaki Inaba; Yoshiki Nishizawa
Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Diabetes research and clinical practice 2009;83(3):320-6.
2004: Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2003: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Kyoko Nagasue; Masaaki Inaba; Senji Okuno; Kayoko Kitatani; Yasuo Imanishi; Eiji Ishimura; Takami Miki; Masao Kim; Yoshiki Nishizawa
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2003;57(2):98-104.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Kiyoshi Maekawa; Kyoko Nagasue; Senji Okuno; Masao Kim; Masanori Emoto; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S76-9.
2002: Misako Ueda; Masaaki Inaba; Senji Okuno; Kyoko Nagasue; Kayoko Kitatani; Eiji Ishimura; Motokazu Shimizu; Takami Miki; Masao Kim; Yoshiki Nishizawa
Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(4):802-9.
2002: Masaaki Inaba; Kyoko Nagasue; Senji Okuno; Misako Ueda; Yasuro Kumeda; Yasuo Imanishi; Tetsuo Shoji; Eiji Ishimura; Tomohiro Ohta; Tatsuya Nakatani; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2001: Masaaki Inaba; Senji Okuno; Kyoko Nagasue; T Otoshi; Y Kurioka; Kiyoshi Maekawa; Yasuro Kumeda; Yasuo Imanishi; Eiji Ishimura; T Ohta; Hirotoshi Morii; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S139-42.